Enrichment of CD4+ and CD8+ T lymphocytes with a column-free flow-based device for clinical cell manufacturing

Overview
This study put MARS Bar, a column-free flow-based magnetic selection platform, to work enriching T cells from human leukapheresis collections at two sites. CD3+ purity was 95.51% on fresh and 93.13% on thawed material, with recovery of 64.68% and 57.06%, in under an hour of run time.
What this paper found
MARS Bar, a column-free, flow-based and fully closed magnetic selection platform, enriched CD4+ and CD8+ T cells from human leukopaks with high purity in under an hour of run time. With quarter leukopaks of about 2.5 × 10^9 cells, CD3+ purity reached 95.51% for fresh and 93.13% for thawed product, and CD3+ recovery was 64.68% and 57.06%. The selection step lasted 39 to 55 minutes. Adding automated LOVO washing in place of manual centrifugation gave total processing of about 130 minutes, with post-selection CD3+ purity of 96.8% in buffer and 95.8% in T-cell medium and CD3+ recovery of 71.0% in buffer. Runs were done at two sites using few leukopaks.
Note: Each condition was tested on one or two leukopaks; the authors plan further work, including T cell isolation from whole blood.
This feature will allow skipping of the buffer exchange step before seeding selected T cells in G-Rex for manufacture of cell therapies. — Paulina Langa, Kriti Sharma, David L. Sellers, Veronica Placencia, Eric A. Smith, Dan Fick, John R. Wilson, Silin Sa, Nathaniel Ortega, Liping Yu, Yuchen Zhou, Ignacio Núñez, Amittha Wickrema, Cytotherapy
Study details
- Authors
- Paulina Langa, Kriti Sharma, David L. Sellers, Veronica Placencia, Eric A. Smith, Dan Fick, John R. Wilson, Silin Sa, Nathaniel Ortega, Liping Yu, Yuchen Zhou, Ignacio Núñez, Amittha Wickrema
- Institution
- Advanced Cellular Therapeutics Facility (ACTF), University of Chicago Medical Center, Chicago, Illinois, USA · Department of Medicine, Section of Hematology/Oncology, Chicago, Illinois, USA · CellReady LLC, Houston, Texas, USA · Applied Cells Inc., Santa Clara, California, USA
- Journal
- Cytotherapy
- Year
- 2025
- PMID / PMC
- PMID: 39891633
- Cell type(s)
- T-Cells
- Study phase
- Preclinical
Full citation
Langa P, Sharma K, Sellers DL, et al. Enrichment of CD4+ and CD8+ T lymphocytes with a column-free flow-based device for clinical cell manufacturing. Cytotherapy. 2025;27(4):534-543.
Building a similar workflow?
Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.